Big Pharma's Got One Toe In, At Least

genomeweb
360dx

Big Pharma's Got One Toe In, At Least

Oct 01, 2007

At VentureBeat, David Hamilton points to news reported in the New York Times of the establishment of the International Serious Adverse Events Consortium.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Methylation-Based Cancer Early Detection Method Shows Promise in Preliminary Studies
Adaptive Biotechnologies, U of Florida, Kings College London Collaborate on Diabetes Study
Pregnancy-Related Immune Changes Revealed by Single-Cell Placenta Sequencing
New Mosquito Genome Expected to Serve as Infectious Disease Resource
CareDx Prices $49M Common Stock Offering
BioLegend, VIB Partner on Single-Cell Protein, RNA Analysis Tech

The Scan

Halt Under Consideration

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

How's It Going to Go Over?

The Associated Press reports that gene-edited food may soon be for sale.

Meetings on Fetal Research

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

This Week in Cell

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.

Main menu